Kardium key facts
as of Oct 2026- Developer of medical devices designed to help in the diagnosis and treatment of atrial fibrillation.
- It has raised $575.2M across 3 recorded rounds; the latest was Later Stage VC ($104.0M) in May 2024.
- Notable investors include Fidelity Management & Research Company, Qatar Investment Authority, T. Rowe Price Group, Fidelity, Durable Capital Partners — 15 tracked in total.
- 2 institutional filers report fund marks on Kardium across 8 filings.
- Kardium has filed 3 Form Ds with the SEC since 2010, most recently Apr 2021 ($116.3M sold to 29 investors).
- Status: Privately Held (backing).
- ·The complete investor list: 15 names
- ·Watch Kardium: the Monday email on marks, rounds and moves
Institutional fund marks on Kardium
2 filers · latest Jul 20262 SEC-registered funds reported 8 fair-value marks on Kardium between Jun 2026 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.
Membership and data by Private Market View
Kardium funding rounds
3 roundsWho backs Kardium
15+Recent activity
In the last 90 days, Kardium's record added 4 institutional fund marks (latest period Jul 2026).
How much has Kardium raised?
Kardium has raised $575 million in total; 3 of its rounds are on record, from 2014 on. The largest on record was a $269,228 seed round in Mar 2014; the most recent was a $104 million later-stage round in May 2024.
Kardium has filed 3 Form Ds with the SEC since 2010, most recently in Apr 2021 ($116 million sold to 29 investors).
Institutional holders and vehicles
2 SEC-registered funds reported 8 fair-value marks on Kardium between Jun 2026 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
Kardium investors
15 investors are on record for Kardium, including Fidelity Management & Research Company, Qatar Investment Authority, T. Rowe Price Group and Fidelity. By type, the record holds 2 family offices, 2 asset managers and 1 hedge fund. The later-stage round in May 2024 drew 2 investors.
About Kardium
Developer of medical devices designed to help in the diagnosis and treatment of atrial fibrillation. The company's devices provide electrophysiological mapping, stimulation, and pulsed field energy to map and ablate cardiac tissue, enabling medical practitioners to diagnose and treat cardiovascular diseases with ease.
- Industry
- Diagnostic Equipment
- Sector
- Healthcare
- HQ
- Burnaby, Canada
- Founded
- 2007
- Employees
- 450
- Website
- kardium.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.